Utilization of pain and sedation therapy on noninvasive mechanical ventilation in Korean intensive care units: a multi-center prospective observational study
2
조회
0
다운로드
3
인용
0
참고문헌
키워드
초록
Background: The use of sedative drugs may be an important therapeutic intervention during noninvasive ventilation (NIV) in intensive care units (ICUs). The purpose of this study was to assess the current application of analgosedation in NIV and its impact on clinical outcomes in Korean ICUs. Methods: Twenty Korean ICUs participated in the study, and data was collected on NIV use during the period between June 2017 and February 2018. Demographic data from all adult patients, NIV clinical parameters, and hospital mortality were included. Results: A total of 155 patients treated with NIV in the ICUs were included, of whom 26 received pain and sedation therapy (sedation group) and 129 did not (control group). The primary cause of ICU admission was due to acute exacerbation of obstructed lung disease (45.7%) in the control group and pneumonia treatment (53.8%) in the sedation group. In addition, causes of NIV application included acute hypercapnic respiratory failure in the control group (62.8%) and post-extubation respiratory failure in the sedation group (57.7%). Arterial partial pressure of carbon dioxide (PaCO2) levels before and after 2 hours of NIV treatment were significantly decreased in both groups: from 61.9±23.8 mm Hg to 54.9±17.6 mm Hg in the control group (P<0.001) and from 54.9±15.1 mm Hg to 51.1±15.1 mm Hg in the sedation group (P=0.048). No significant differences were observed in the success rate of NIV weaning, complications, length of ICU stay, ICU survival rate, or hospital survival rate between the groups. Conclusions: In NIV patients, analgosedation therapy may have no harmful effects on complications, NIV weaning success, and mortality compared to the control group. Therefore, sedation during NIV may not be unsafe and can be used in patients for pain control when indicated.
Abstract
Background: The use of sedative drugs may be an important therapeutic intervention during noninvasive ventilation (NIV) in intensive care units (ICUs). The purpose of this study was to assess the current application of analgosedation in NIV and its impact on clinical outcomes in Korean ICUs. Methods: Twenty Korean ICUs participated in the study, and data was collected on NIV use during the period between June 2017 and February 2018. Demographic data from all adult patients, NIV clinical parameters, and hospital mortality were included. Results: A total of 155 patients treated with NIV in the ICUs were included, of whom 26 received pain and sedation therapy (sedation group) and 129 did not (control group). The primary cause of ICU admission was due to acute exacerbation of obstructed lung disease (45.7%) in the control group and pneumonia treatment (53.8%) in the sedation group. In addition, causes of NIV application included acute hypercapnic respiratory failure in the control group (62.8%) and post-extubation respiratory failure in the sedation group (57.7%). Arterial partial pressure of carbon dioxide (PaCO2) levels before and after 2 hours of NIV treatment were significantly decreased in both groups: from 61.9±23.8 mm Hg to 54.9±17.6 mm Hg in the control group (P<0.001) and from 54.9±15.1 mm Hg to 51.1±15.1 mm Hg in the sedation group (P=0.048). No significant differences were observed in the success rate of NIV weaning, complications, length of ICU stay, ICU survival rate, or hospital survival rate between the groups. Conclusions: In NIV patients, analgosedation therapy may have no harmful effects on complications, NIV weaning success, and mortality compared to the control group. Therefore, sedation during NIV may not be unsafe and can be used in patients for pain control when indicated.
참고문헌 (18)
- Walkey AJ, "Use of noninvasive ventilation in patients with acute respiratory failure, 2000-2009 : a populationbased study", Ann Am Thorac Soc, 10, pp.10~17 (2013)
- Girou E, "Secular trends in nosocomial infections and mortality associated with noninvasive ventilation in patients with exacerbation of COPD and pulmonary edema", JAMA, 290, pp.2985~2991 (2003)
- Hilbert G, "Is sedation safe and beneficial in patients receiving NIV? Yes", Intensive Care Med, 41, pp.1688~1691 (2015)
- Carron M, "Complications of non-invasive ventilation techniques : a comprehensive qualitative review of randomized trials", Br J Anaesth, 110, pp.896~914 (2013)
- Conti G, "Sedation with sufentanil in patients receiving pressure support ventilation has no effects on respiration : a pilot study", Can J Anaesth, 51, pp.494~499 (2004)
- Ethuin F, "Pharmacokinetics of long-term sufentanil infusion for sedation in ICU patients", Intensive Care Med, 29, pp.1916~1920 (2003)
- Constantin JM, "Remifentanil-based sedation to treat noninvasive ventilation failure : a preliminary study", Intensive Care Med, 33, pp.82~87 (2007)
- Akada S, "The efficacy of dexmedetomidine in patients with noninvasive ventilation : a preliminary study", Anesth Analg, 107, pp.167~170 (2008)
- Clouzeau B, "Target-controlled infusion of propofol for sedation in patients with non-invasive ventilation failure due to low tolerance : a preliminary study", Intensive Care Med, 36, pp.1675~1680 (2010)
- Rocco M, "Rescue treatment for noninvasive ventilation failure due to interface intolerance with remifentanil analgosedation : a pilot study", Intensive Care Med, 36, pp.2060~2065 (2010)
- Huang Z, "Dexmedetomidine versus midazolam for the sedation of patients with non-invasive ventilation failure", Intern Med, 51, pp.2299~2305 (2012)
- 남현승, "Current Status of Noninvasive Ventilation Use in Korean Intensive Care Units: A Prospective Multicenter Observational Study", Tuberculosis and Respiratory Diseases, 82(3), pp.242~250 (2019), 대한결핵및호흡기학회
- Demoule A, "Changing use of noninvasive ventilation in critically ill patients : trends over 15 years in francophone countries", Intensive Care Med, 42, pp.82~92 (2016)
- Demoule A, "Increased use of noninvasive ventilation in French intensive care units", Intensive Care Med, 32, pp.1747~1755 (2006)
- Shaheen M, "Outcomes and predictors of success of noninvasive ventilation in acute exacerbation of chronic obstructive pulmonary disease", Egypt Bronchology, 12, pp.329~339 (2018)
- Moretti M, "Incidence and causes of non-invasive mechanical ventilation failure after initial success", Thorax, 55, pp.819~825 (2000)
- Soo Hoo GW, "Nasal mechanical ventilation for hypercapnic respiratory failure in chronic obstructive pulmonary disease : determinants of success and failure", Crit Care Med, 22, pp.1253~1261 (1994)
- Devlin JW, "Survey of sedation practices during noninvasive positive-pressure ventilation to treat acute respiratory failure", Crit Care Med, 35, pp.2298~2302 (2007)